Next Article in Journal
Genomic Characterization of Drug-Resistant Mycobacterium tuberculosis L2/Beijing Isolates from Astana, Kazakhstan
Next Article in Special Issue
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020
Previous Article in Journal
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion
Previous Article in Special Issue
In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020
 
 
Review

Article Versions Notes

Antibiotics 2023, 12(10), 1522; https://doi.org/10.3390/antibiotics12101522
Action Date Notes Link
article xml file uploaded 9 October 2023 13:45 CEST Original file -
article xml uploaded. 9 October 2023 13:45 CEST Update https://www.mdpi.com/2079-6382/12/10/1522/xml
article pdf uploaded. 9 October 2023 13:45 CEST Version of Record https://www.mdpi.com/2079-6382/12/10/1522/pdf
article html file updated 9 October 2023 13:46 CEST Original file https://www.mdpi.com/2079-6382/12/10/1522/html
Back to TopTop